Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Change in Inventory (2016 - 2025)

Amicus Therapeutics' Change in Inventory history spans 10 years, with the latest figure at $44.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory rose 268.52% year-over-year to $44.3 million, compared with a TTM value of $111.5 million through Dec 2025, up 51.36%, and an annual FY2025 reading of $111.5 million, up 51.36% over the prior year.
  • Change in Inventory for Q4 2025 was $44.3 million at Amicus Therapeutics, up from $36.3 million in the prior quarter.
  • The five-year high for Change in Inventory was $44.3 million in Q4 2025, with the low at -$1.8 million in Q1 2022.
  • Average Change in Inventory over 5 years is $12.1 million, with a median of $6.7 million recorded in 2021.
  • Year-over-year, Change in Inventory crashed 395.22% in 2021 and then soared 1510.14% in 2023.
  • Tracing FOLD's Change in Inventory over 5 years: stood at $4.8 million in 2021, then soared by 115.1% to $10.3 million in 2022, then tumbled by 76.78% to $2.4 million in 2023, then skyrocketed by 404.83% to $12.0 million in 2024, then soared by 268.52% to $44.3 million in 2025.
  • Per Business Quant, the three most recent readings for FOLD's Change in Inventory are $44.3 million (Q4 2025), $36.3 million (Q3 2025), and $22.6 million (Q2 2025).